Search Results - "Tiğlioğlu, Pinar"

Refine Results
  1. 1

    A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study by Altin, Nilgun, Tiğlioğlu, Pinar, Ulusoy, Tulay Unver, Aydin, Fevzi Nuri, Kar, İrem, Karakoc, Busra, Utebey, Gulten

    Published in Medicine (Baltimore) (12-04-2024)
    “…COVID-19 disrupts the balance between coagulation and fibrinolysis. Especially in the clinical course of serious disease, plasminogen activator inhibitor-1…”
    Get full text
    Journal Article
  2. 2

    RELAPSED MANTLE CELL LYMPHOMA WITH ISOLATED CENTRAL NERVOUS SYSTEM INVOLVEMENT THAT TREATED WITH IBRUTINIB; A CASE REPORT AND LITERATURE REVIEW by Pinar Tiglioglu, Salih Sertac Durusoy, Melis Mutlu, Mehmet Yilmaz

    Published in Hematology, Transfusion and Cell Therapy (01-10-2022)
    “…Objective: Mantle cell lymphoma (MCL) is an agressive B-cell lymphoma, constitutes 3-10% of all non-Hodgkin's lymphomas. MCL usually presents with generalized…”
    Get full text
    Journal Article
  3. 3

    A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION by Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: Five types of gene variants are seen in hereditary spherocytosis (ANK, SPTB, SPTA1, SLC4A1, EPB42). JAK2 V617F mutation; is most common seen in…”
    Get full text
    Journal Article
  4. 4

    RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH) by YILMAZ, Fatma, ALBAYRAK, Murat, ARAS, Merih REİS, MARAL, Senem, AFACAN ÖZTÜRK, Hacer Berna, TIĞLIOĞLU, Pınar, TIĞLIOĞLU, Mesut, SAĞLAM, Buğra

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving…”
    Get full text
    Journal Article
  5. 5

    A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA by Fatma YILMAZ, Murat ALBAYRAK, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Merih REİS ARAS, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: Pellagra is a systemic disease caused by a deficiency of vitamin B3 .A 19-year-old male patient, who was diagnosed with Burkitt's lymphoma was…”
    Get full text
    Journal Article
  6. 6

    INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT by Merih Reis Aras, Senem Maral, Hacer Berna Afacan Ozturk, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Murat Albayrak, Mustafa Onder

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: Inappropriate ADH syndrome is a cause of hyponatremia with increased ADH secretion despite normal plasma osmolality and euvolemic state.There are…”
    Get full text
    Journal Article
  7. 7

    T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT by Merih Reis Aras, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Senem Maral, Hacer Berna Afacan Ozturk, Murat Albayrak, Neslihan Olgun

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: Ionizing radiation and chemotherapeutic agents can cause carcinogenic effects by causing DNA damage.A 40-year-old female patient diagnosed with…”
    Get full text
    Journal Article
  8. 8

    Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect by Tığlıoğlu, Mesut, Tığlıoğlu, Pınar, Yıldız, Abdulkerim, Reis Aras, Merih, Sağlam, Buğra, Afacan Öztürk, Hacer Berna, Adabağ, Ayşegül, Albayrak, Murat

    “…What is known and objective Primary myelofibrosis (PMF) is characterized by myeloid cell proliferation and prominent bone marrow fibrosis. Ruxolitinib, a…”
    Get full text
    Journal Article
  9. 9

    The outcome of COVID-19 in patients with hematological malignancy by Tığlıoğlu, Pınar, Albayrak, Murat, Tığlıoğlu, Mesut, Öztürk, Hacer Berna Afacan, Aras, Merih Reis, Sağlam, Buğra, Maral, Senem

    “…Summary Objective The aim of this study was to examine the effect of coronavirus disease 2019 (COVID-19) on the malignancy-related clinical course and overall…”
    Get full text
    Journal Article
  10. 10

    Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment by Yılmaz, Fatma, Albayrak, Murat, Tığlıoğlu, Pınar, Tığlıoğlu, Mesut, Sağlam, Buğra, Reis Aras, Merih, Maral, Senem, Afacan Öztürk, Hacer Berna

    Published in Journal of oncology pharmacy practice (01-04-2022)
    “…Introduction Imatinib is generally well tolerated by patients. The most common ophthalmic side effects are eyelid edema and periorbital edema. Other side…”
    Get full text
    Journal Article
  11. 11

    Change in Hepatitis B Surface Antibody Titers After Chemotherapy in Patients With Hematological Malignancies by Unver Ulusoy, Tülay, Tıglıoglu, Pınar, Demirköse, Hacer, Albayrak, Murat, Şencan, İrfan

    Published in Curēus (Palo Alto, CA) (01-01-2024)
    “…Background The change in hepatitis B surface antibody (anti-HBs) titers after chemotherapy (CT) in patients with hematological malignancy, affecting factors,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX by Senem MARAL, Murat ALBAYRAK, Berna AFACAN ÖZTÜRK, Merih REİS ARAS, Fatma YILMAZ, Pınar Tığlıoğlu, Mesut TIĞLIOĞLU, Buğra SAĞLAM

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: Chylothorax is the leakage of chylous contents into the pleural space as a result of damage to the thoracic duct. Chylous effusion is seen often…”
    Get full text
    Journal Article
  14. 14

    A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT by Mesut Tığlıoğlu, Murat Albayrak, Pınar Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: Bone involvement is rare in DLBCL. 70-yearold patient, applied to the orthopedics clinic dueto knee pain. Kneeprosthesis was planned. During…”
    Get full text
    Journal Article
  15. 15

    ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT by Senem MARAL, Murat ALBAYRAK, Hacer Berna OZTURK, MerihREIS ARAS, Fatma YILMAZ, Pınar TIGLIOGLU, Mesut TIGLIOGLU, Buğra SAGLAM

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: T-cell prolymphocytic leukemia (T-PLL) is a rare and highly aggressive T cell neoplasm with rapidly progressing clinical course. T-PLL accounts for…”
    Get full text
    Journal Article
  16. 16

    A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA by Pınar Tığlıoğlu, Mesut Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk, Murat Albayrak

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: We wanted to present our patient who was diagnosed with NK/T cell type PTLD after kidney transplantation, to contribute to the…”
    Get full text
    Journal Article
  17. 17

    CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER by Mesut Tığlıoğlu, Pınar Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk, Murat Albayrak

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Case report: In this article, we wanted to present our case in which we detected SMZL during examining for defects in coagulation tests and correlated the PT…”
    Get full text
    Journal Article
  18. 18

    A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA by Buğra Sağlam, Murat Albayrak, Hacer Berna Afacan Öztürk, Merih Reis Aras, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Fatma Yılmaz, Senem Maral

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: Congenital dyserythropoietic anemia is a group of diseases characterized by ineffective erythropoiesis and multinuclear erythroblasts, mostly…”
    Get full text
    Journal Article
  19. 19

    Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 by TIĞLIOĞLU, Pınar, ALBAYRAK, Murat, AFACAN ÖZTÜRK, Hacer Berna, TIĞLIOĞLU, Mesut, SAĞLAM, Buğra, REİS ARAS, Merih, YILMAZ, Fatma, MARAL, Senem, MALKAN, Ümit Yavuz

    Published in Sağlłk akademisi Kastamonu (23-06-2022)
    “…Introduction Coronavirus disease 2019 (COVID-19) were declared as pandemic by World Health Organization. With this study, we aimed to define our patients who…”
    Get full text
    Journal Article
  20. 20

    A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME by Buğra Sağlam, Murat Albayrak, Hacer Berna Afacan Öztürk, Merih Reis Aras, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Fatma Yılmaz, Senem Maral, Mustafa Önder

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: Although plasma cell neoplasms occupy a large place in hematology practice, POEMS syndrome is very rare. Serum lambda light chain elevation and…”
    Get full text
    Journal Article